Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
出版年份 2021 全文链接
标题
Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
作者
关键词
-
出版物
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-06
DOI
10.1186/s12951-021-01017-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin
- (2021) Shen-Jun Yuan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Stromal PD-1+ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma
- (2020) Lu Chen et al. HUMAN PATHOLOGY
- Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
- (2020) Poonam Sarode et al. Frontiers in Oncology
- Anti–PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells
- (2020) Ganesh Rao et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis
- (2020) Dong-Jer Shiau et al. Scientific Reports
- Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
- (2020) María Ochoa de Olza et al. LANCET ONCOLOGY
- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy
- (2019) Tong-Fei Li et al. Acta Biomaterialia
- Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion
- (2019) Bin Li et al. Oncogenesis
- Upregulation of PD-L1 via HMGB1-activated IRF3 and NF-kB contributes to UV radiation-induced immune suppression
- (2019) Wei Wang et al. CANCER RESEARCH
- Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma
- (2019) Jizhuang Wang et al. JOURNAL OF IMMUNOTHERAPY
- M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling
- (2019) Zhaoyun Zong et al. Frontiers in Immunology
- Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse
- (2019) Tadashi ASHIZAWA et al. BIOMEDICAL RESEARCH-TOKYO
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
- (2019) Shen-Jun Yuan et al. JOURNAL OF NANOBIOTECHNOLOGY
- Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
- (2019) Di Lu et al. Journal of Immunology Research
- Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
- (2019) Xiaoqiang Liu et al. Environmental Health and Preventive Medicine
- Monocyte-mediated chemotherapy drug delivery in glioblastoma
- (2018) Chao Wang et al. Nanomedicine
- Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
- (2018) Genevieve P Hartley et al. Cancer Immunology Research
- Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma
- (2018) Tong-Fei Li et al. BIOMATERIALS
- Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
- (2018) Hongshu Sui et al. Journal of Immunology Research
- Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment
- (2017) Tong-Fei Li et al. JOURNAL OF CONTROLLED RELEASE
- Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
- (2017) Katarzyna Guzik et al. JOURNAL OF MEDICINAL CHEMISTRY
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling
- (2017) Chenyan Li et al. THYROID
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
- (2016) Krzysztof M. Zak et al. Oncotarget
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
- (2015) Wenchao Zhou et al. NATURE CELL BIOLOGY
- Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells
- (2014) Li Zhao et al. BIOMATERIALS
- Myeloid IKK Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response
- (2014) J. Yang et al. CANCER RESEARCH
- Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-κB activation and CYP2E1 content of rats with immunological liver injury
- (2014) Jin-dong Qin et al. PHARMACEUTICAL BIOLOGY
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Ménage à Trois in stress: DAMPs, redox and autophagy
- (2013) Guanqiao Li et al. SEMINARS IN CANCER BIOLOGY
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function
- (2012) K. D. Grugan et al. JOURNAL OF IMMUNOLOGY
- Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis
- (2009) Shaival H. Davé et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More